Ibsa Pharma Inc.

NJ · United States · Reporting entity ID 100000226810

Total reported 2019–2025

$1.66M

#1,108 of 2,960 reporting companies — 0% of all reported industry payments

$1.42M in general payments across 57,241 records, plus $245K in research funding across 26 records.

How it breaks down

General payments $1,416,907

Research funding $244,541

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.